Your browser doesn't support javascript.
loading
Role of IL-35 in sublingual allergen immunotherapy.
Shamji, Mohamed H; Layhadi, Janice A; Achkova, Daniela; Kouser, Lubna; Perera-Webb, Alan; Couto-Francisco, Natália C; Parkin, Rebecca V; Matsuoka, Tomokazu; Scadding, Guy; Ashton-Rickardt, Philip G; Durham, Stephen R.
Afiliação
  • Shamji MH; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom. Electronic address: m.shamji@imperial.
  • Layhadi JA; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Achkova D; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Kouser L; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Perera-Webb A; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Couto-Francisco NC; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Parkin RV; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Matsuoka T; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Scadding G; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Ashton-Rickardt PG; Section of Immunobiology, Division of Immunology and Inflammation, Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Durham SR; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, and the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
J Allergy Clin Immunol ; 143(3): 1131-1142.e4, 2019 03.
Article em En | MEDLINE | ID: mdl-30053528

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pólen / Alérgenos / Linfócitos / Rinite Alérgica Sazonal / Interleucinas / Imunoterapia Sublingual / Poaceae Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pólen / Alérgenos / Linfócitos / Rinite Alérgica Sazonal / Interleucinas / Imunoterapia Sublingual / Poaceae Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2019 Tipo de documento: Article